Dublin biotech firm aims to take a slice of gluten-free market

Taking a hi-tech approach to gluten detection, Dublin company Allogen Biotech is aiming to take a slice of the multibillion-euro global gluten-free market.
Adapting sensors which have previously been used in medical diagnostics, Allogen has created a unique device which can be used by manufacturers to check, control and manage gluten levels during the production process.